Upstream Bio, Inc. (UPB)
7.145
-0.04
(-0.49%)
USD |
NASDAQ |
Aug 26, 13:42
Upstream Bio Total Assets (Quarterly) : 281.17M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 281.17M |
| March 31, 2026 | 318.05M |
| December 31, 2025 | 353.77M |
| September 30, 2025 | 391.20M |
| Date | Value |
|---|---|
| June 30, 2025 | 420.52M |
| March 31, 2025 | 456.17M |
| December 31, 2024 | 481.72M |
| September 30, 2024 | 232.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sutro Biopharma, Inc. | 194.46M |
| Compass Therapeutics, Inc. | 190.17M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.21M |
| Shareholders Equity (Quarterly) | 270.96M |
| Debt to Equity Ratio | 0.0035 |
| Current Ratio | 27.99 |
| Net Debt Paydown Yield | 0.04% |